Shimadzu Corporation invested in Persist AI Formulation Corp (Persist AI, based in California) through the Corporate Venture Capital (CVC) fund “Shimadzu Future Innovation Fund” (Shimadzu FIF). The company is developing a platform that utilizes AI and robotics to streamline the formulation of pharmaceuticals. The formulation process, which involves processing the pharmaceutical active ingredients into useful […]
Shimadzu Corporation has invested in U.S. startup SUN METALON Inc. (Sun Metalon, Illinois) through its corporate venture capital (CVC) fund, “Shimadzu Future Innovation Fund”. Sun Metalon is developing solution to recycle scrap metal generated by the automotive, construction machinery, and steel manufacturing industries at the sites. Despite its potential value, scrap metal generated at manufacturing […]
On Wednesday, May 21 2025, ORYL Photonics introduces the ORYL F1, a novel automated laser-based platform for the measurement of solubility and aggregation of drug molecules in the Life Science industry. This is a significant achievement for the fast-growing Swiss company and for the solubility and aggregation community. The laboratory instrument enables researchers to make […]
MILFORD, Mass. — Waters Corporation (NYSE:WAT) today announced that it has acquired Halo Labs™, an innovator of specialized imaging technologies to detect, identify, and count interfering materials (particles) in therapeutic products, such as cell, protein, and gene therapies. The Aura™ platform from Halo Labs features a highly differentiated technology that performs full spectrum particle analysis and […]
News Summary Saves up to six months on compliant software validation in biopharmaceutical quality control.1 Reduces analysis time for biotherapeutic peptides and proteins by 20%.2 Enhances quality control by providing absolute molecular weight of biologics and avoiding common errors encountered with other techniques.3 MILFORD, Mass. — Waters Corporation (NYSE:WAT) today announced that its Empower™ Software now […]
Investment demonstrates confidence in America’s commitment to science and innovation WALTHAM, Mass. — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, will invest an additional $2 billion in the United States over the next four years, strengthening American innovation, manufacturing and economic competitiveness across the life sciences sector. As one of […]
Shimadzu Corporation has invested in RLWRLD Inc. (RLWRLD), through its Corporate Venture Capital (CVC) fund, “Shimadzu Future Innovation Fund” (Shimadzu FIF). RLWRLD is developing AI foundation models for humanoid and other types of robots used in the manufacturing industry. The reductions in the labor force caused by population decline and aging are emerging as social […]
The collaboration aims to provide advanced resources and scientific expertise to accelerate innovation and drive sustainable growth SINGAPORE — Thermo Fisher Scientific Inc, the world leader in serving science, has signed a strategic Memorandum of Understanding with NSG BIO, Singapore’s largest BSL-2-certified, co-working laboratory and office space. This collaboration aims to empower biotech startups in Singapore with access to […]
Shimadzu Scientific Instruments, Inc. (SSI, Columbia, Maryland, USA), a Shimadzu Group company, has opened a satellite lab in Boston, Massachusetts to be the base of its collaborative research and development activities on the East Coast. Established to conduct research and development more closely linked to customers, SSI’s R&D Center consists of three bases, with the […]
On February 21, Shimadzu Scientific Korea Corporation (SSK), a subsidiary of Shimadzu in South Korea, and Chungnam National University signed a memorandum of understanding (MOU) with the objectives of strengthening the development of technology and research equipment, and promoting collaborative research between industry and academia. Chungnam National University, which was established in 1952 in Daejeon […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
